» Articles » PMID: 34946139

The Roles of the Virome in Cancer

Overview
Journal Microorganisms
Specialty Microbiology
Date 2021 Dec 24
PMID 34946139
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Viral infections as well as changes in the composition of the intestinal microbiota and virome have been linked to cancer. Moreover, the success of cancer immunotherapy with checkpoint inhibitors has been correlated with the intestinal microbial composition of patients. The transfer of feces-which contain mainly bacteria and their viruses (phages)-from immunotherapy responders to non-responders, known as fecal microbiota transplantation (FMT), has been shown to be able to convert some non-responders to responders. Since phages may also increase the response to immunotherapy, for example by inducing T cells cross-reacting with cancer antigens, modulating phage populations may provide a new avenue to improve immunotherapy responsiveness. In this review, we summarize the current knowledge on the human virome and its links to cancer, and discuss the potential utility of bacteriophages in increasing the responder rate for cancer immunotherapy.

Citing Articles

Role of bacteria in cancers and their therapeutic potential: Review of current knowledge.

Wawrety W, Kedziora A Iran J Basic Med Sci. 2025; 28(3):273-282.

PMID: 39906620 PMC: 11790194. DOI: 10.22038/ijbms.2024.77667.16798.


Blood virome research in myalgic encephalomyelitis/chronic fatigue syndrome: challenges and opportunities.

Obraitis D, Li D Curr Opin Virol. 2024; 68-69:101437.

PMID: 39537445 PMC: 11795702. DOI: 10.1016/j.coviro.2024.101437.


Investigation of Epstein-Barr virus, Cytomegalovirus, Human herpesvirus 6, and Polyoma viruses (JC virus, BK virus) among Gastric cancer patients: A cross sectional study.

Soltani S, Farahani A, Shahbahrami R, Shateri Z, Emadi M, Pakzad R Health Sci Rep. 2024; 7(4):e2043.

PMID: 38650724 PMC: 11033485. DOI: 10.1002/hsr2.2043.


Gut virome in inflammatory bowel disease and beyond.

Tun H, Peng Y, Massimino L, Sin Z, Parigi T, Facoetti A Gut. 2023; 73(2):350-360.

PMID: 37949638 PMC: 10850733. DOI: 10.1136/gutjnl-2023-330001.


Role of the microbiota in response to and recovery from cancer therapy.

Blake S, Wolf Y, Boursi B, Lynn D Nat Rev Immunol. 2023; 24(5):308-325.

PMID: 37932511 DOI: 10.1038/s41577-023-00951-0.


References
1.
Aarnoutse R, Ziemons J, Penders J, Rensen S, de Vos-Geelen J, Smidt M . The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy. Int J Mol Sci. 2019; 20(17). PMC: 6747354. DOI: 10.3390/ijms20174145. View

2.
Hassan M, Li D, El-Deeb A, Wolff R, Bondy M, Davila M . Association between hepatitis B virus and pancreatic cancer. J Clin Oncol. 2008; 26(28):4557-62. PMC: 2562875. DOI: 10.1200/JCO.2008.17.3526. View

3.
Gilbert J, Blaser M, Caporaso J, Jansson J, Lynch S, Knight R . Current understanding of the human microbiome. Nat Med. 2018; 24(4):392-400. PMC: 7043356. DOI: 10.1038/nm.4517. View

4.
Roux S, Hallam S, Woyke T, Sullivan M . Viral dark matter and virus-host interactions resolved from publicly available microbial genomes. Elife. 2015; 4. PMC: 4533152. DOI: 10.7554/eLife.08490. View

5.
Sharma P, Hu-Lieskovan S, Wargo J, Ribas A . Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy. Cell. 2017; 168(4):707-723. PMC: 5391692. DOI: 10.1016/j.cell.2017.01.017. View